Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland

INTRODUCTION: Currently, 15–20% of individuals with coronary artery disease (chronic coronary syndrome [CCS]) or peripheral artery disease (PAD) receiving routine treatment experience cardiovascular events (CVEs) within 3–4 years. Using PICOSTEPS (Patients-Intervention-Comparators-Outcomes-Setting-T...

Full description

Saved in:
Bibliographic Details
Published in:Adv Ther
Main Authors: Soini, Erkki, Virtanen, Outi, Väätäinen, Saku, Briere, Jean-Baptiste, Bowrin, Kevin, Millier, Aurelie
Format: Artigo
Language:Inglês
Published: Springer Healthcare 2020
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467417/
https://ncbi.nlm.nih.gov/pubmed/32519113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01398-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items